Showing 1 - 13 results of 13 for search 'David Viswanatha', query time: 0.04s
Refine Results
-
1
Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases by Maymona G. Abdelmagid, Mark R. Litzow, Kristen B. McCullough, Naseema Gangat, Animesh Pardanani, Hemant S. Murthy, James M. Foran, Rhett P. Ketterling, David Viswanatha, Kebede H. Begna, Ayalew Tefferi
Published 2022-07-01
Article -
2
DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation by Majd Jawad, Michelle Afkhami, Michelle Afkhami, Yi Ding, Xiaohui Zhang, Peng Li, Kim Young, Mina Luqing Xu, Wei Cui, Yiqing Zhao, Stephanie Halene, Aref Al-Kali, David Viswanatha, Dong Chen, Rong He, Gang Zheng, Gang Zheng
Published 2022-02-01
Article -
3
Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study by Zhuoer Xie, Ahmad Nanaa, Antoine N. Saliba, Rong He, David Viswanatha, Phuong Nguyen, Dragan Jevremovic, Patricia Greipp, Mohamad E. Salama, Naseema Gangat, Hassan B. Alkhateeb, Ayalew Tefferi, Mark Litzow, Mrinal Patnaik, Mithun Shah, Aref Al-Kali
Published 2021-03-01
Article -
4
P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE by Rami Basmaci, Anmol Baranwal, Rong He, David Viswanatha, Patricia Greipp, James M Foran, Cecilia Arana Yi, Mithun Shah, Abhishek Mangaonkar, Mark Litzow, William Hogan, Kebede Benga, Antoine Saliba, Naseema Gangat, Ayalew Tefferi, Mrinal Patnaik, Aref Al-Kali, Hassan Alkhateeb
Published 2023-08-01
Article -
5
Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience by Ahmad Nanaa, David Viswanatha, Zhuoer Xie, Dragan Jevremovic, Phuong Nguyen, Mohamad E. Salama, Patricia Greipp, Kurt Bessonen, Naseema Gangat, Mrinal Patnaik, Animesh Pardanani, Hassan B. Alkhateeb, Mithun Shah, William Hogan, Ayalew Tefferi, Mark Litzow, Rong He, Aref Al-Kali
Published 2021-06-01
Article -
6
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity by Talha Badar, Yenny A. Moreno Vanegas, Ahmad Nanaa, James M. Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B. Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R. Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M. Patnaik
Published 2023-09-01
Article -
7
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome by Aref Al-Kali, Ahmad Nanaa, David Viswanatha, Rong He, Phuong Nguyen, Dragan Jevremovic, James M. Foran, Cecelia Arana Yi, Patricia T. Greipp, Naseema Gangat, Mrinal Patnaik, Ayalew Tefferi, Mark R. Litzow, Abhishek A. Mangaonkar, Mithun Vinod Shah, Talha Badar, Hassan B. Alkhateeb
Published 2023-04-01
Article -
8
P734: CLONAL HEIRARCHY AND HETEROGENEITY IN STAG2M MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE by Bahga Katamesh, Ahmad Nanaa, Rong He, David Viswanatha, Patricia Greipp, Phuong Nguyen, Dragan Jevremovic, Cecilia Arana Yi, James M Foran, Kebede Benga, Naseema Gangat, Abhishek Mangaonkar, Antoine Saliba, Mrinal Patnaik, William Hogan, Mark Litzow, Ayalew Tefferi, Mithun Shah, Hassan Alkhateeb, Aref Al-Kali
Published 2023-08-01
Article -
9
P747: CLINICAL CHARACTERISTICS AND OUTCOME OF EZH2-MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE by Muhamad Oum, Ahmad Nanaa, Amrutha Mittapalli, Rong He, David Viswanatha, Patricia Greipp, Phuong Nguyen, Dragan Jevremovic, Cecilia Arana Yi, James M Foran, Kebede Benga, Naseema Gangat, Abhishek Mangaonkar, Antoine Saliba, Mrinal Patnaik, William Hogan, Mark Litzow, Ayalew Tefferi, Mithun Shah, Hassan Alkhateeb, Aref Al-Kali
Published 2023-08-01
Article -
10
Myeloid malignancies with 5q and 7q deletions are associated with extreme genomic complexity, biallelic TP53 variants, and very poor prognosis by Beth A. Pitel, Neeraj Sharma, Cinthya Zepeda-Mendoza, James B. Smadbeck, Kathryn E. Pearce, Joselle M. Cook, George Vasmatzis, Zohar Sachs, Rashmi Kanagal-Shamanna, David Viswanatha, Sheng Xiao, Robert B. Jenkins, Xinjie Xu, Nicole L. Hoppman, Rhett P. Ketterling, Jess F. Peterson, Patricia T. Greipp, Linda B. Baughn
Published 2021-02-01
Article -
11
P722: CHARACTERISATION OF PHF6 MUTATIONS IN MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE by Amrutha Sai Mittapalli, Bahga Katamesh, Muhamad Oum, Rong He, David Viswanatha, Patricia Greipp, Phuong Nguyen, Dragan Jevremovic, Cecilia Arana Yi, James M Foran, Kebede Benga, Naseema Gangat, Abhishek Mangaonkar, Antoine Saliba, Mrinal Patnaik, William J Hogan, Mark Litzow, Ayalew Tefferi, Mithun Shah, Hassan Alkhateeb, Aref Al-Kali
Published 2023-08-01
Article -
12
Mayo Clinic experience with 1123 adults with acute myeloid leukemia by Kebede H. Begna, Walid Ali, Naseema Gangat, Michelle A. Elliott, Aref Al-Kali, Mark R. Litzow, C. Christopher Hook, Alexandra P. Wolanskyj-Spinner, William J. Hogan, Mrinal M. Patnaik, Animesh Pardanani, Darci L. Zblewski, Dong Chen, Rong He, David Viswanatha, Curtis A. Hanson, Rhett P. Ketterling, Ayalew Tefferi
Published 2021-03-01
Article -
13
Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia by Beth A. Pitel, Cinthya Zepeda-Mendoza, Zohar Sachs, Hongwei Tang, Suganti Shivaram, Neeraj Sharma, James B. Smadbeck, Stephanie A. Smoley, Kathryn E. Pearce, Ivy M. Luoma, Joselle Cook, Mark R. Litzow, Nicole L. Hoppman, David Viswanatha, Xinjie Xu, Rhett P. Ketterling, Patricia T. Greipp, Jess F. Peterson, Linda B. Baughn
Published 2023-09-01
Article